K232330 is an FDA 510(k) clearance for the Lancing System, a Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature (Class II — Special Controls, product code QRK), submitted by Ningbo Medsun Medical Co., Ltd. (Ningbo, CN). The FDA issued a Cleared decision on January 4, 2024, 154 days after receiving the submission on August 3, 2023. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4850.
| 510(k) Number | K232330 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | August 03, 2023 |
| Decision Date | January 04, 2024 |
| Days to Decision | 154 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | QRK — Single Use Only Blood Lancet Without An Integral Sharps Injury Prevention Feature |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4850 |
| Definition | A Disposable Blood Lancet Intended For A Single Use That Is Comprised Of A Single Use Blade Attached To A Solid, Nonreusable Base That Is Used To Puncture The Skin To Obtain A Drop Of Blood For Diagnostic Purposes. |